definiens: means any biological products that are demonstrated to be to or with an FDA - licensed biologic product developed by or on behalf of Coherus following theEffective Date and during the Option Term, other than the Products as of the Effective Date . The biosimilarproduct for [ * * * ] .shall not be an Option Product if Coherus has granted [ * * * ] no later than twelve ( 12 ) months aftermarketing authorization has been obtained by Coherus from the regulatory authorities in any of [ * * * ] . For clarity, ifCoherus does not grant such commercialization rights [ * * * ] within twelve ( 12 ) months after such marketingauthorization has been obtained, the biosimilar product for [ * * * ] shall be an and Distributor shallhave a period of ninety ( 90 ) days after receipt of notice from Coherus of such Option Product ’s availability inwhich to exercise the Option for such Option Product